Close Menu

In this week's Science, researchers from the Broad Institute report a new version of the genome-editing technology CRISPR that targets RNA rather than DNA. Unlike traditional CRISPR systems that use Cas9 to cleave target DNA, the new approach — called REPAIR — uses Cas13b fused to the adenosine deaminase domain of ADAR2 to achieve precise A to I edits.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.